Pathway / Mechanistic Context BPC-157 is used to probe VEGFR2-associated signaling, nitric oxide-related processes, and focal adhesion signaling involved in cytoskeletal anchoring and cell migration
The honest answer is that the BPC-157 before and after timeline is real, but it is not uniform
Gut and inflammation: Individuals with persistent digestive discomfort where gut barrier support is clinically relevant, people with suspected gut-inflammation overlap contributing to fatigue or poor systemic recovery, and those with a history of NSAID-related gut irritation
These effects occurred more frequently at higher doses and were generally consistent with the known side effect profile of incretin-based therapies
doi:10.1016/j.pbi.2007.04.009
With respect to BPC 157, they might both augment heparin and warfarin effects and thereby BPC 157 would have a changed effect (however, as emphasized, BPC 157 always reduced the amount of bleeding)